COLLPLANT BIOTECH. IS-01 Cash Flow-to-Debt Ratio
COLLPLANT BIOTECH. IS-01 cash flow-to-debt ratio. COLLPLANT BIOTECH. IS-01 (CPT) has a Cash Flow-to-Debt Ratio of -0.71x as of March 2026, meaning its operating cash flow of €-3.05 Million could theoretically repay -1% of its total liabilities (€4.30 Million) in one year. Check CPT cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of COLLPLANT BIOTECH. IS-01 (2021–2025)
Cash flow-to-debt ratio of COLLPLANT BIOTECH. IS-01 from 2021 to 2025. Historical debt coverage capacity for COLLPLANT BIOTECH. IS-01 across 5 annual periods. Check COLLPLANT BIOTECH. IS-01 (CPT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
COLLPLANT BIOTECH. IS-01 Cash Flow-to-Debt Ratio by Year (2021–2025)
COLLPLANT BIOTECH. IS-01 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for COLLPLANT BIOTECH. IS-01. For the full cash flow conversion analysis, see how efficiently does COLLPLANT BIOTECH. IS-01 generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.00x | €-9.42 Million | €4.70 Million | ▲ +25.5% |
| 2024 | -2.69x | €-14.09 Million | €5.25 Million | ▼ -462.7% |
| 2023 | -0.48x | €-2.76 Million | €5.79 Million | ▲ +80.9% |
| 2022 | -2.50x | €-13.70 Million | €5.49 Million | ▼ -709.2% |
| 2021 | 0.41x | €2.50 Million | €6.10 Million | — |